Teleflex Incorporated (NYSE:TFX) Shares Bought by Villere ST Denis J & Co. LLC

Villere ST Denis J & Co. LLC grew its position in shares of Teleflex Incorporated (NYSE:TFX) by 9.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 149,276 shares of the medical technology company’s stock after acquiring an additional 12,296 shares during the quarter. Teleflex comprises 2.4% of Villere ST Denis J & Co. LLC’s portfolio, making the stock its 21st biggest position. Villere ST Denis J & Co. LLC owned about 0.32% of Teleflex worth $26,568,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Simplify Asset Management Inc. acquired a new stake in Teleflex during the third quarter worth about $4,800,000. JPMorgan Chase & Co. increased its stake in Teleflex by 14.3% during the third quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company’s stock worth $38,374,000 after acquiring an additional 19,466 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. increased its stake in Teleflex by 5.2% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 108,231 shares of the medical technology company’s stock worth $19,263,000 after acquiring an additional 5,322 shares during the last quarter. LGT Capital Partners LTD. increased its stake in Teleflex by 4.2% during the third quarter. LGT Capital Partners LTD. now owns 231,685 shares of the medical technology company’s stock worth $57,300,000 after acquiring an additional 9,411 shares during the last quarter. Finally, Boston Trust Walden Corp increased its stake in Teleflex by 3.9% during the fourth quarter. Boston Trust Walden Corp now owns 294,614 shares of the medical technology company’s stock worth $52,435,000 after acquiring an additional 11,052 shares during the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages have commented on TFX. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Mizuho lowered their target price on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, November 1st. Royal Bank of Canada lowered their target price on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Finally, Truist Financial lowered their target price on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research note on Wednesday, December 18th. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $252.50.

Teleflex Trading Down 0.1 %

Shares of TFX opened at $167.44 on Friday. The company has a market capitalization of $7.78 billion, a P/E ratio of 33.29, a P/E/G ratio of 1.72 and a beta of 1.16. Teleflex Incorporated has a one year low of $166.76 and a one year high of $256.85. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The stock has a 50-day moving average price of $178.49 and a 200 day moving average price of $209.78.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.